1. Home
  2. BLTE vs IFS Comparison

BLTE vs IFS Comparison

Compare BLTE & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Belite Bio Inc

BLTE

Belite Bio Inc

N/A

Current Price

$129.67

Market Cap

6.0B

Sector

Health Care

ML Signal

N/A

Logo Intercorp Financial Services Inc.

IFS

Intercorp Financial Services Inc.

N/A

Current Price

$47.39

Market Cap

5.6B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BLTE
IFS
Founded
2018
1897
Country
United States
Peru
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
6.0B
5.6B
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
BLTE
IFS
Price
$129.67
$47.39
Analyst Decision
Strong Buy
Buy
Analyst Count
9
3
Target Price
★ $233.00
$65.23
AVG Volume (30 Days)
142.0K
★ 193.7K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
★ 3.56%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$26.33
Revenue Next Year
N/A
$6.14
P/E Ratio
★ N/A
$9.61
Revenue Growth
N/A
N/A
52 Week Low
$115.41
$39.51
52 Week High
$200.00
$61.38

Technical Indicators

Market Signals
Indicator
BLTE
IFS
Relative Strength Index (RSI) 32.18 38.00
Support Level N/A $46.49
Resistance Level $158.76 $51.89
Average True Range (ATR) 9.11 1.69
MACD -1.46 0.08
Stochastic Oscillator 19.04 19.47

Price Performance

Historical Comparison
BLTE
IFS

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

About IFS Intercorp Financial Services Inc.

Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services, and payments for retail customers and commercial clients in Peru. Its purpose is centered around building financial well-being together. The company has three operating business segments: Banking, mainly loans, credit facilities, deposits, and current accounts; Insurance provides life annuity products with single-premium payment and conventional life insurance products, as well as other retail insurance products; and Wealth management provides brokerage and investment management services. Inteligo serves mainly Peruvian citizens.

Share on Social Networks: